None listed
Conditions
Brief summary
This study aimed to evaluate the effects of functional motor training and functional motor training combined with biofeedback on lumbopelvic range of motion, movement quality, brain bioelectrical activity, balance, perceived stress, and mood states in women aged 35–50 years with chronic low back pain. Participants were randomly allocated to a functional motor training group, a functional motor training with biofeedback group, or a control group. The intervention lasted 8 weeks, followed by a follow-up assessment. Outcomes were assessed using three-dimensional motion analysis, electroencephalography (EEG), stabilometric platforms, and validated psychological questionnaires. The study provides a comprehensive biopsychosocial evaluation of therapeutic interventions in chronic low back pain.
Interventions
Arm 1: Functional motor training (MCT) Participants performed a structured functional motor training program for 8 weeks (2 sessions per week) under the supervision of a physiotherapist. Each session lasted approximately 45 minutes and was delivered in small groups. Sessions were conducted twice weekly with at least 48 hours between sessions. Exercise intensity was maintained at a moderate level and was individually adjusted according to participant tolerance and progression. The program consisted of three components: (1) motor control and stabilization exercises focusing on the lumbopelvic region, (2) strengthening exercises (e.g. squats, deadlifts, hip bridge, dead bug, Pallof press), and (3) stretching exercises aimed at improving flexibility and reducing muscle tension. Adherence to the intervention was monitored using attendance records completed by the supervising physiotherapist at each session. Arm 2: Functional motor training with biofeedback (MCT-BF) Participants performed the same functional motor training program as in Arm 1, with additional biofeedback-based training. Each session lasted approximately 60 minutes, including 15 minutes of biofeedback training performed on ALFA and SIGMA stabilometric platforms. Sessions were delivered in small groups under the supervision of a physiotherapist and were conducted twice weekly with at least 48 hours between sessions. The biofeedback component consisted of static and dynamic balance exercises and proprioceptive tasks performed on stabilometric platforms. Participants received real-time visual feedback displayed on a monitor regarding body sway and centre of pressure displacement. Interactive game-based tasks requiring weight shifting, balance control, and postural adjustments were also performed. The purpose of the biofeedback training was to improve postural control, proprioception, and neuromuscular coordination. Exercise intensity was maintained at a moderate level and was individually adjusted according to participant tolerance and progression. Adherence to the intervention was monitored using attendance records completed by the supervising physiotherapist at each session. Arm 3: Control group (CG) Participants in the control group did not receive any intervention during the study period and were instructed to continue their usual daily activities. Outcome assessments were performed at the same time points as in the intervention groups.
Sponsors
Study design
Eligibility
Inclusion criteria
- Female participants aged 35–50 years - Chronic low back pain lasting at least 12 weeks - Body mass index (BMI) between 18.5 and 30 kg/m² - Ability to participate in physical training and functional testing - Ability to complete psychological questionnaires - No severe psychiatric disorders - Written informed consent to participate in the study
Exclusion criteria
- Acute or severe chronic diseases (e.g. infections) - Autoimmune diseases (e.g. rheumatoid arthritis, multiple sclerosis, lupus) - Active or past cancer - Advanced degenerative spinal changes or acute disc herniation - Cardiovascular diseases (e.g. heart failure, arrhythmia) - Endocrine disorders (e.g. diabetes, thyroid disorders) - Neurological disorders (e.g. epilepsy, neurodegenerative diseases) - Use of painkillers, anti-inflammatory or psychotropic medications - Substance abuse - Severe psychiatric disorders - Cognitive impairment - Sleep disorders - Pregnancy or breastfeeding